February 2026 Investor Presentation

• Revenue up 9% to $31.3m vs 1H25
• NPBT up 8% to $7.5m vs 1H25
• Operating cash inflow up 44% to $6.4m vs 1H25

XRF Scientific Ltd, a leading provider of laboratory products and analytical instruments, has reported a strong set of financial results for the first half of the 2026 financial year. Revenue increased by 9% to $31.3 million compared to the first half of FY25, driven by continued strong demand from mining and industrial customers, as well as growing international sales. Net profit before tax (NPBT) rose by 8% to $7.5 million, while operating cash inflow surged 44% to $6.4 million. The company's Precious Metals division saw a 22% increase in revenue and a 49% jump in NPBT, benefiting from high precious metal prices, including platinum. The Capital Equipment division also performed well, with revenue up 20% and NPBT up 24%, boosted by strong sales of the Orbis laboratory crushers and the xrTGA thermal analyzer. XRF Scientific's balance sheet remains robust, with a net cash position of $11 million and a reduction in liabilities. The company is focused on driving further growth through initiatives such as new product releases, geographical expansion, and potential acquisitions of complementary businesses.

XRF Scientific expects continued strong demand from mining and industrial customers, with international sales expected to accelerate. The company is forecasting revenue growth and improved profitability for the full 2026 financial year.

XRF Scientific is well-positioned for further growth, with a focus on ramping up sales of the xrTGA analyzer, growing Orbis laboratory crusher sales globally, and expanding its portfolio of gold sector analysis products. The company will also continue to pursue M&A opportunities to complement its existing product range.